News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SR ONE CAPITAL MANAGEMENT, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
SC 13D/A
| SR ONE CAPITAL MANAGEMENT, LLC reports a 8.2% stake in Arcellx, Inc. |
| 05/19/2023 |
SC 13D/A
| SR ONE CAPITAL MANAGEMENT, LLC reports a 9.4% stake in Arcellx, Inc. |
| 05/15/2023 |
4
| SR ONE CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 4 on Arcellx, Inc.|
Txns:
| Sold 631,932 shares
@ $45, valued at
$28.4M
Sold 370,612 shares
@ $45, valued at
$16.7M
Sold 6,485 shares
@ $46.15, valued at
$299.3k
Sold 3,804 shares
@ $46.15, valued at
$175.6k
|
|
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 12/20/2022 |
4
| SR One Capital Fund I Aggregator LP (10% Owner) has filed a Form 4 on Design Therapeutics, Inc.|
Txns:
| Bought 500,000 shares
@ $8.2811, valued at
$4.1M
Bought 360,000 shares
@ $8.6336, valued at
$3.1M
Bought 40,000 shares
@ $8.1358, valued at
$325.4k
|
|
| 06/27/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/17/2022 |
SC 13D
| SR ONE CAPITAL MANAGEMENT, LLC reports a 15.8% stake in Arcellx, Inc. |
| 02/11/2022 |
SC 13G
| SR ONE CAPITAL MANAGEMENT, LLC reports a 16.9% stake in eFFECTOR Therapeutics, Inc. |
| 02/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
|
|